Biomarkers as a diagnostic tool for irritable bowel syndrome: where are we?

被引：42

作者：

Camilleri, Michael ^{[1
]}

Halawi, Houssam ^{[1
]}

Oduyebo, Ibironke ^{[1
]}

机构：

[1] Clin Enter Neurosci Translat & Epidemiol Res, Mayo Clin, Rochester, MN USA

来源：

EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY | 2017年 / 11卷 / 04期

基金：

美国国家卫生研究院;

关键词：

Bile acid; chromogranin; enterochromaffin cells; irritable bowel syndrome; lymphocytes; mast cells; microbiome; proteases; scintigraphic transit; visceral sensation; PLACEBO-CONTROLLED TRIAL; SERINE-PROTEASE ACTIVITY; BILE-ACID MALABSORPTION; VISCERAL HYPERSENSITIVITY; COLONIC TRANSIT; CONSTIPATION-PREDOMINANT; ULCERATIVE-COLITIS; FECAL CALPROTECTIN; IMMUNE ACTIVATION; CHROMOGRANIN-A;

D O I：

10.1080/17474124.2017.1288096

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

Introduction: Irritable bowel syndrome (IBS) is a common condition in clinical practice. There are currently no objective tests to rule in the disease, but rather tests to rule out other diseases. Biomarkers in IBS may provide the tools needed for diagnosis, prognosis and therapy. These include identification of differences in microbial composition, immune activation, bile acid composition, colonic transit, and alteration in sensation in subgroups of IBS patients. Areas covered: Studies included in our review were chosen based on a PubMed search for 'biomarkers' and 'IBS'. We have reviewed the literature on biomarkers to appraise their accuracy, validity and whether they are actionable. We have not covered genetic associations as biomarkers in this review. Expert commentary: There is significant promise in the usefulness of biomarkers for IBS. The most promising actionable biomarkers are markers of changes in bile acid balance, such as elevated bile acid in the stool, and altered colonic transit. However, there is also potential for microbial studies and mucosal proteases as future actionable biomarkers.

引用

页码：303 / 316

页数：14

共 111 条

[31] Randomized, double-blind, placebo-controlled trial of prednisolone in post-infectious irritable bowel syndrome [J].

Dunlop, SP ;

Jenkins, D ;

Neal, KR ;

Naesdal, J ;

Borgaonker, M ;

Collins, SM ;

Spiller, RC .

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2003, 18 (01) :77-84

[32] Low Densities of Serotonin and Peptide YY Cells in the Colon of Patients with Irritable Bowel Syndrome [J].

El-Salhy, M. ;

Gundersen, D. ;

Ostgaard, H. ;

Lomholt-Beck, B. ;

Hatlebakk, J. G. ;

Hausken, T. .

DIGESTIVE DISEASES AND SCIENCES, 2012, 57 (04) :873-878

[33] Chromogranin A as a possible tool in the diagnosis of irritable bowel syndrome [J].

El-Salhy, Magdy ;

Lomholt-Beck, Bjarne ;

Hausken, Trygve .

SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2010, 45 (12) :1435-1439

[34] Mucosal inflammation as a potential etiological factor in irritable bowel syndrome: a systematic review [J].

Ford, Alexander C. ;

Talley, Nicholas J. .

JOURNAL OF GASTROENTEROLOGY, 2011, 46 (04) :421-431

[35] Elevated circulating miR-150 and miR-342-3p in patients with irritable bowel syndrome [J].

Fourie, Nicolaas H. ;

Peace, Ralph Michael ;

Abey, Sarah K. ;

Sherwin, LeeAnne B. ;

Rahim-Williams, Bridgett ;

Smyser, Paul A. ;

Wiley, John W. ;

Henderson, Wendy A. .

EXPERIMENTAL AND MOLECULAR PATHOLOGY, 2014, 96 (03) :422-425

[36] Increased faecal serine protease activity in diarrhoeic IBS patients: a colonic lumenal factor impairing colonic permeability and sensitivity [J].

Gecse, K. ;

Roka, R. ;

Ferrier, L. ;

Leveque, M. ;

Eutamene, H. ;

Cartier, C. ;

Ait-Belgnaoui, A. ;

Rosztoczy, A. ;

Izbeki, F. ;

Fioramonti, J. ;

Wittmann, T. ;

Bueno, L. .

GUT, 2008, 57 (05) :591-598

[37] Prevalence of, and predictors of, bile acid malabsorption in outpatients with chronic diarrhea [J].

Gracie, D. J. ;

Kane, J. S. ;

Mumtaz, S. ;

Scarsbrook, A. F. ;

Chowdhury, F. U. ;

Ford, A. C. .

NEUROGASTROENTEROLOGY AND MOTILITY, 2012, 24 (11) :983-e538

[38] Psychological factors selectively upregulate rectal pain perception in hypersensitive patients with irritable bowel syndrome [J].

Grinsvall, C. ;

Tornblom, H. ;

Tack, J. ;

Van Oudenhove, L. ;

Simren, M. .

NEUROGASTROENTEROLOGY AND MOTILITY, 2015, 27 (12) :1772-1782

[39] DISCRIMINANT VALUE OF PSYCHOLOGICAL DISTRESS, SYMPTOM PROFILES, AND SEGMENTAL COLONIC DYSFUNCTION IN OUTPATIENTS WITH SEVERE IDIOPATHIC CONSTIPATION [J].

GROTZ, RL ;

PEMBERTON, JH ;

TALLEY, NJ ;

RATH, DM ;

ZINSMEISTER, AR .

GUT, 1994, 35 (06) :798-802

[40] 13C mannitol as a novel biomarker for measurement of intestinal permeability [J].

Grover, M. ;

Camilleri, M. ;

Hines, J. ;

Burton, D. ;

Ryks, M. ;

Wadhwa, A. ;

Sundt, W. ;

Dyer, R. ;

Singh, R. J. .

NEUROGASTROENTEROLOGY AND MOTILITY, 2016, 28 (07) :1114-1119

← 1 2 3 4 5 6 7 8 9 10 →